RYTM financials
Rhythm Pharmaceuticals (RYTM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RYTM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $189.76M | $170.26M | -$192.02M | -$196.54M | -3.11 |
| 2024 | $130.13M | $116.76M | -$265.50M | -$260.60M | -4.34 |
| 2023 | $77.43M | $68.13M | -$184.36M | -$184.68M | -3.20 |
| 2022 | $23.64M | $21.50M | -$179.16M | -$181.12M | -3.51 |
| 2021 | $3.15M | $2.56M | -$170.06M | -$69.61M | -1.37 |
| 2020 | $0.00 | -$690.00K | -$136.57M | -$130.73M | -2.96 |
- RYTM revenue was $189.76M in fiscal 2025, net income -$196.54M.
Updated 2026-11-03 00:03 UTC